News

Article

Paxlovid and long COVID; hearing loss and dementia risk; $93M in health care fraud - Morning Medical Update

The top news stories in primary care today.

Doctor morning desk: © Alena Kryazheva – stock.adobe.com

Doctor morning desk: © Alena Kryazheva – stock.adobe.com

Paxlovid vs. long COVID

Long COVID occurs in about 10% of patients with COVID-19 globally and could affect up to 65 million people worldwide. Researchers found patients treated with nirmatrelvir-ritonavir (Paxlovid) did not show a lower prevalence of long COVID symptoms 90 days after infection.

Hearing against dementia

Even mild hearing loss is associated with an increased risk of dementia. But a new study involving more than 573,000 participants in Denmark suggests hearing aids may reduce risk of dementia.

$93M in medical fraud

A federal judge handed down sentences for a home health therapy and money laundering fraud scheme that billed Medicare $93 million for services never provided, according to the U.S. Department of Justice. A 42-year-old man was sentenced to eight years and four months in prison, while a 54-year-old woman co-conspirator was sentenced to five years and 10 months in prison. They were convicted at a jury trial of using stolen patient identities and individuals in Cuba in the scheme.

Newsletter

Stay informed and empowered with Medical Economics enewsletter, delivering expert insights, financial strategies, practice management tips and technology trends — tailored for today’s physicians.

Related Videos
Succeeding in value-based payment: A conversation with Joshua M. Liao, MD
Succeeding in value-based payment: A conversation with Joshua M. Liao, MD
Succeeding in value-based payment: A conversation with Joshua M. Liao, MD
Succeeding in value-based payment: A conversation with Joshua M. Liao, MD
Succeeding in value-based payment: A conversation with Joshua M. Liao, MD
ACP policy update 2025: A conversation with Brian E. Outland, PhD
ACP policy update 2025 interview
ACP policy update 2025 interview
ACP policy update 2025 interview